Offers 81.8 per cent of the share’s closing price before the company announced updated financial targets last week.
Less than 30 minutes ago
Updated just now
The matter is being updated…
Carasent reports this in a stock exchange announcement on Monday morning.
EG is offering a price of NOK 20 per share, which corresponds to 81.8 per cent of the Carasent share’s closing price on 23 April. The date was the last trading day before the company published its report for the first quarter of 2024.
The bid corresponds to a price of approximately NOK 1.4 billion.
According to the stock exchange announcement, the offer has already received “strong support” from key shareholders who represent 34 percent of the share capital in Carasent, including the main shareholder Acaptial Cara Holdco.
Mikkel Bardram, CEO of EG, says in a comment that he believes the acquisition will be in the interests of both the employees, customers and shareholders.
Updated financial targets
Carasent delivers IT solutions within health.
When the company presented its report for the first quarter, the company announced updated financial targets.
Revenues are expected to be NOK 270 million in 2024, corresponding to 15 percent organic growth, and in 2025 Carasent expects them to increase to NOK 320 million, corresponding to organic growth of 20 percent.
Carnegie acts as financial advisor to EG in connection with the acquisition, and the law firm Arntzen de Besche takes care of the legal matters.
